Charles Explorer logo
🇬🇧

Research Report University Hospital clinical trial OM-EPA-011

Publication

Abstract

A 12-Week, Randomized, Double-Blind, Olive Oil-Controlled Phase 3 Study to Assess the Efficacy and Safety of EPANOVATM in Subjects With Severe Hypertriglyceridemia (EVOLVE II)